Image via WikipediaNext big thing? Big cholesterol drop with new drug - Health - Heart health - msnbc.com
- Font:
CHICAGO — An experimental Merck drug safely boosted good cholesterol to record highs while dropping bad cholesterol to unprecedented lows in a study that stunned researchers and renewed hopes for an entirely new way of lowering heart risks.
"We are the most excited we have been in decades" about a novel drug, said the study's leader, Dr. Christopher Cannon, of Brigham and Women's Hospital in Boston. "This could really be the next big thing."
The drug, anacetrapib, won't be on the market anytime soon. It needs more testing to see if its dramatic effects on cholesterol will translate into fewer heart attacks, strokes and deaths. Merck & Co. announced a 30,000-patient study to answer that question and it will take several years.
- Health highlights
- Autism risk rises in closely spaced pregnanciesGetty images
A new, large study shows that the risk of autism rose three-fold when a child was conceived within 12 months of the birth of a first baby. - Latin lovers? Frigid Brits? Mythbusting sexy stereotypes
- Number of young people in nursing homes rising
- Holding a grudge can be good for your marriage
- Children of rape: Latest legacy of Haiti quake
But the sheer magnitude of its effects so far caused big excitement at an American Heart Association conference in Chicago, where results were presented on Wednesday.
Story: Why dark chocolate boosts heart health"The data look spectacular, beyond what anybody would have expected," said Dr. Robert Eckel, a University of Colorado cardiologist and past president of the heart association. "It's like a rocket to Jupiter versus one to the moon. I can think of many of my patients who could use the drug right now."
Merck's Dr. Luciano Rossetti agreed.
"We are trying not to be too giddy. The potential benefit is enormous," said Rossetti, senior vice president of global scientific strategy at the company, based in Whitehouse Station, New Jersey.
For years, doctors have focused on lowering LDL, or bad cholesterol, to cut heart risks. Statin medicines, sold as Lipitor, Zocor and in generic form, do this. But many statin users still suffer heart attacks, so doctors have been trying to get LDL to very low levels and to boost HDL, or good cholesterol.
No comments:
Post a Comment